CaixaBank, S.A.’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
CaixaBank, S.A.'s ALNY Position: Q3 2026 in Review
CaixaBank, S.A. increased its Alnylam Pharmaceuticals (ALNY) stake by 62% in Q3 2026, buying an estimated $2.25M and bringing the position to 23,258 shares worth $5.74M. The position accounts for 0.03% of the portfolio, ranked #266.
CaixaBank, S.A. first reported a position in ALNY in Q2 2020 and has held it in 26 quarters since. The position peaked at $12.1M in Q2 2024. 726 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- CaixaBank, S.A. held 23,258 shares of Alnylam Pharmaceuticals worth $5.74M as of Q3 2026.
- CaixaBank, S.A. bought 8,859 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $2.25M.
- Alnylam Pharmaceuticals made up 0.03% of CaixaBank, S.A.'s portfolio in Q3 2026, its #266 holding.
- CaixaBank, S.A. first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 26 quarters since.
- CaixaBank, S.A.'s Alnylam Pharmaceuticals position peaked at $12.1M in Q2 2024.
- 726 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.